1-1 of 1
Jeffrey Ciavarri
Close
Save search
Sort by
Journal Articles

Preclinical Combination Of The Oral Investigational Agents ACY-1215, a Selective HDAC6 Inhibitor, and Ixazomib, a Proteasome Inhibitor, Demonstrates Combination Benefit In Multiple Myeloma Cell Lines and Xenograft Models

Free
Allison J Berger, PhD, Bret Bannerman, Steven N Quayle, PhD, Jie Yu, Khristofer Garcia, Jeffrey Ciavarri, PhD, David Tamang, PhD, Min Yang, PhD, Simon S Jones, PhD
Journal: Blood
Blood (2013) 122 (21): 4437.
https://doi.org/10.1182/blood.V122.21.4437.4437
Published: 2013